A Study in Chinese Patients to Compare How Tenecteplase and Alteplase Given After a Stroke Improve Recovering of Physical Activity
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1489 participants.
Also called NCT04915729
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,489 participants
- Sponsor
- Registry
-
NCT04915729
-
- Other papers using this trial's data
- Tenecteplase vs Alteplase for Patients With Acute Ischemic Stroke: The ORIGINAL Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT04915729. Randomized; single masking; primary purpose treatment. Start 2021-06-22 (actual); primary completion 2023-10-08 (actual). Results posted on 2024-12-10.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study in Chinese Patients to Compare How Tenecteplase and Alteplase Given After a Stroke Improve Recovering of Physical Activity
- Acronym
- ORIGINAL
- Condition
- Stroke
- Intervention (Drug)
- tenecteplase
- Intervention (Drug)
- alteplase
- Lead sponsor
- Boehringer Ingelheim
Record details
- Record id
cardio:ct-nct04915729- Content hash
8fc81e62ffb30b28a1e6e5051a22f6eeeac9e1d4fe07a4ad35895e25d45d12f3